GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Innophos Holdings Inc (NAS:IPHS) » Definitions » Debt-to-EBITDA

Innophos Holdings (Innophos Holdings) Debt-to-EBITDA : 4.06 (As of Sep. 2019)


View and export this data going back to 2006. Start your Free Trial

What is Innophos Holdings Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Innophos Holdings's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2019 was $6.8 Mil. Innophos Holdings's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2019 was $389.1 Mil. Innophos Holdings's annualized EBITDA for the quarter that ended in Sep. 2019 was $97.5 Mil. Innophos Holdings's annualized Debt-to-EBITDA for the quarter that ended in Sep. 2019 was 4.06.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Innophos Holdings's Debt-to-EBITDA or its related term are showing as below:

IPHS's Debt-to-EBITDA is not ranked *
in the Chemicals industry.
Industry Median: 2.28
* Ranked among companies with meaningful Debt-to-EBITDA only.

Innophos Holdings Debt-to-EBITDA Historical Data

The historical data trend for Innophos Holdings's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Innophos Holdings Debt-to-EBITDA Chart

Innophos Holdings Annual Data
Trend Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18
Debt-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.03 2.54 1.64 2.99 2.96

Innophos Holdings Quarterly Data
Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.35 3.21 3.73 3.64 4.06

Competitive Comparison of Innophos Holdings's Debt-to-EBITDA

For the Specialty Chemicals subindustry, Innophos Holdings's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Innophos Holdings's Debt-to-EBITDA Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, Innophos Holdings's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Innophos Holdings's Debt-to-EBITDA falls into.



Innophos Holdings Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Innophos Holdings's Debt-to-EBITDA for the fiscal year that ended in Dec. 2018 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(0 + 300) / 101.331
=2.96

Innophos Holdings's annualized Debt-to-EBITDA for the quarter that ended in Sep. 2019 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(6.83 + 389.077) / 97.468
=4.06

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Sep. 2019) EBITDA data.


Innophos Holdings  (NAS:IPHS) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Innophos Holdings Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Innophos Holdings's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Innophos Holdings (Innophos Holdings) Business Description

Traded in Other Exchanges
N/A
Address
259 Prospect Plains Road, Cranbury, NJ, USA, 08512
Innophos Holdings Inc is a holding company that manufactures and sells through its subsidiaries a variety of ingredients used in the production of food, beverages, dietary supplements, pharmaceuticals, and oral care products. Innophos ingredients are made primarily from specialty phosphates. The company organizes itself into three segments namely Food, Health and Nutrition; Industrial Specialties and Other. The Food, Health and Nutrition segment contribute the maximum revenue. The company operates in U.S., Canada, Mexico and other countries.
Executives
John M Steitz director ALBEMARLE CORP, 451 FLORIDA ST, BATON ROUGE LA 70801
Kim Ann Mink director, officer: Chairman, CEO, President 259 PROSPECT PLAINS RD., BLDG A, CRANBURY NJ 08512
Gary A Cappeline director 50 E RIVERCENTER BLVD, COVINGTON KY 41012
Karen R Osar director C/O WESTVACO CORP, ONE HIGH RIDGE PARK, STAMFORD CT 06905
Mark Santangelo officer: Sr. VP, Mfg, Eng & EH&S 15710 JOHN F. KENNEDY BLVD., SUITE 300 HOUSTON TX 77032
Peter T Thomas director 1000 LAKESIDE AVENUE, CLEVELAND OH 44114
Hermanus Kieftenbeld officer: Senior VP and CFO 259 PROSPECT PLAINS RD., BLDG A, CRANBURY NJ 08512
James P. Zallie director 5 WESTBROOK CORPORATE CENTER, WESTCHESTER IL 60154
Randy Gress director, officer: CEO 259 PROSPECT PLAINS ROAD, P O BOX 8000, CRANBURY NJ 08512-8000
Stephen M Zide director BAIN CAPITAL PARTNERS, JOHN HANCOCK TOWER, 200 CLARENDON STREET, BOSTON MA 02116
Richard Heyse officer: VP-Chief Financial Officer 259 PROSPECT PLAINS ROAD, BUILDING G, P O BOX 8000, CRANBURY NJ 08512-8000
Bain Capital Investors Llc 10 percent owner 200 CLARENDON STREET, BOSTON MA 02116
Bain Capital Partners Vii Lp 10 percent owner JOHN HANCOCK TOWER, 200 CLARENDON STREET, BOSTON MA 02116
Bain Capital Fund Vii Llc 10 percent owner JOHN HANCOCK TOWER, 200 CLARENDON STREET, BOSTON MA 02116
Bain Capital Fund Vii Lp 10 percent owner JOHN HANCOCK TOWER, 200 CLARENDON STREET, BOSTON MA 02116

Innophos Holdings (Innophos Holdings) Headlines

From GuruFocus

INNOPHOS HOLDINGS, INC. (IPHS) CEO Randy Gress sells 20,000 Shares

By GuruFocus Research GuruFocus Editor 08-18-2010

Innophos Holdings: Will the Aggressive M&A Drive Pay Off?

By John Engle John Engle 03-29-2018